Ginkgo Biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats

Otology and Neurotology

Volumn 28, Issue 6, 2007, Pages 828-833

  Huang, Xinyan ^a   Whitworth, Craig A ^a   Rybak, Leonard P ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cisplatin; EGb 761; Ginkgo biloba extract; Otoprotection; Ototoxicity; Rat

Indexed keywords

CISPLATIN; FREE RADICAL; GINKGO BILOBA EXTRACT; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COCHLEA POTENTIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; LIPID PEROXIDATION; MALE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; COCHLEA; COCHLEAR MICROPHONIC POTENTIALS; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GINKGO BILOBA; HAIR CELLS, AUDITORY, INNER; HAIR CELLS, AUDITORY, OUTER; HEARING DISORDERS; MALE; MICROSCOPY, ELECTRON, SCANNING; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; TEMPORAL BONE;

EID: 34548246598     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3180430163     Document Type: Article

References (61)

1. Hartmann JT, Lipp H-P. Toxicity of platinum compounds. Expert Opin Pharmacother 2003;4:889-901.
2. Boulikas T, Vougiouka M. Recent clinical trail using cisplatin, carboplatin and their combination chemotherapy drugs. Oncol Rep 2004;11:559-95.
3. Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 1995;76:386-94.
4. Watanabe K, Hess A, Bloch W, et al. Nitric oxide synthase inhibitor suppresses the ototoxic side effects of cisplatin in guinea pigs. Anticancer Drugs 2000;11:401-6.
5. Kelly TC, Whitworth CA, Husain K, et al. Aminoguanidine reduces cisplatin ototoxicity. Hear Res 2003;186:10-6.
6. Lee JE, Nakagawa T, Kim TS, et al. Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment. Acta Otolaryngol 2004;124:1131-5.
7. Rybak LP, Kelly T. Ototoxicity: bioprotective mechanisms. Curr Opin Otolaryngol Head Neck Surg 2003;11:328-33.
8. Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today 2005;10:1313-21.
9. Gandara DR, Perez EA, Weibe V, et al. Cisplatin chemoprotection and rescue: pharmacologic modulation of toxicity. Semin Oncol 1991;18:49-55.
10. Leitao DJ, Blakley BW. Quantification of sodium thiosulphate protection on cisplatin-induced toxicities. J Otolaryngol 2003;32:146-50.
11. Hussain AE, Blakley BW, Nicolas M, et al. Assessment of protective effects of amifostine against cisplatin-induced toxicity. J Otolaryngol 2003;32:294-7.
12. Rybak LP, Ravi R, Somani SM. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam Appl Toxicol 1995;26:293-300.
13. Campbell KCM, Rybak LP, Meech RP. D-Methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 1996;102:90-8.
14. Campbell KCM, Meech RP, Rybak LP, et al. The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection. J Am Acad Audiol 2003;14:144-56.
15. Hamers FPT, Brakkee JH, Cavalletti E, et al. Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res 1993;53:544-9.
16. Campbell KCM, Larsen DL, Meech RP, et al. Glutathione ester but not glutathione protects against cisplatin-induced ototoxicity in a rat model. J Am Acad Audiol 2003;14:124-33.
17. Fetoni AR, Sergi B, Ferraresi A, et al. Protective effects of alphatocopherol and tiopronin against cisplatin-induced ototoxicity. Acta Otolaryngol 2004;124:421-6.
18. Kalkanis JG, Whitworth C, Rybak LP. Vitamin E reduces cisplatin ototoxicity. Laryngoscope 2004;114:538-42.
19. Greggi Antunes LM, Darin JD, Bianchi MD. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res 2000;41:405-11.
20. Lopez-Gonzalez MA, Guerrero JM, Rojas F, et al. Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants. J Pineal Res 2000;28:73-80.
21. Li G, Sha S-H, Zotova E, et al. Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab Invest 2003;82:585-96.
22. Feghali JG, Liu W, Van De Water TR. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 2001;111:1147-55.
23. Wu YJ, Muldoon LL, Neuwelt EA. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther 2005;312:424-31.
24. Choe W, Chinosornvatana N, Chang KW. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otol Neurotol 2004;25:910-5.
25. Major RT. The ginkgo, the most ancient living tree. The resistance of Ginkgo biloba L. to pests accounts in part for the longevity of this species. Science 1967;15:1270-3.
26. Drieu K. Preparation and definition of Ginkgo biloba extract. In: Funfgeld EW, ed. Rokan (Ginkgo biloba): Recent Results in Pharmacology and Clinic. Berlin, Germany: Springer-Verlag, 1988:32-6.
27. Clostre F. From the body to the cell membrane: the different levels of pharmacological action of Ginkgo biloba extract. Presse Med 1986;15:1529-38.
28. Oyama Y, Chikahisa L, Ueha T, et al. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res 1996;712:349-52.
29. Rong YQ, Geng ZH, Lau BHS. Ginkgo biloba attenuates oxidative stress in macrophages and endothelial cells. Free Radic Biol Med 1996;20:121-7.
30. Pincemail J, Düpuis M, Nasr C, et al. Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract. Experientia 1989;45:708-12.
31. Maitra I, Marcocci L, Droy-Lefaix MT, et al. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem Pharmacol 1995;49:1649-55.
32. Yoshikawa I, Naito Y, Kondo M. Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid Redox Signal 1999;1:469-80.
33. Bridi R, Crossetti FP, Steffen VM, et al. The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. Phytother Res 2001;15:449-51.
34. Kose K, Dogan P. Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 2. Comparison of the antioxidant effects of Ginkgo biloba extract (EGb 761) with those of water-soluble and lipid-soluble antioxidants. J Int Med Res 1995;23:9-18.
35. Sharma HS, Drieu K, Alm P, et al. Role of nitric oxide in blood-brain barrier permeability, brain edema and cell damage following hyperthermic brain injury. An experimental study using EGb-761 and Gingkolide B pretreatment in the rat. Acta Neurochir Suppl 2000;76:81-6.
36. Wong A, Dukic-Stefanovic A, Gasic-Milenkovic J, et al. Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia. Eur J Neurosci 2001;14:1961-7.
37. Christen Y, Maixent J-M. What is Ginkgo biloba extract EGb 761? An overview - from molecular biology to clinical medicine. Cell Mol Biol 2002;48:601-11.
38. Dehne N, Lautermann J, Petrat F, et al. Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 2001;174:27-34.
39. Gosepath K, Gath I, Maurer J, et al. Characterization of nitric oxide synthase isoforms expressed in different structures of the guinea pig cochlea. Brain Res 1997;747:26-33.
40. Heinrich UR, Maurer J, Gosepath K, et al. Electron microscopic localization of nitric oxide I synthase in the organ of Corti of the guinea pig. Eur Arch Otorhinolaryngol 1997;254:396-400.
41. Vass Z, Brechtelsbauer PB, Nuttall AL, et al. Nitric oxide mediates capsaicin-induced increase in cochlear blood flow. Hear Res 1996;100:114-9.
42. Ren T, Nuttall AL, Miller JM. ATP-induced cochlear blood flow changes involve the nitric oxide pathway. Hear Res 1997;112: 87-94.
43. Crow JP, Beckman JS. The role of peroxynitrite in nitric oxide-mediated toxicity. In: Koprowski H, Maeda H, eds. The Role of Nitric Oxide in Physiology and Pathophysiology. Berlin, Germany: Springer-Verlag, 1995:57-73.
44. van Ruijven MW, de Groot JC, Hendriksen F, et al. Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs. Hear Res 2005;203:112-21.
45. Liu W, Staecker H, Stupak H, et al. Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. Neuroreport 1998;9:2609-14.
46. Wang J, Ladrech S, Pujol R, et al. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. Cancer Res 2004;64:9217-24.
47. Comis SD, Rhys-Evans PH, Osborne MP, et al. Early morphological and chemical changes induced by cisplatin in the guinea pig organ of Corti. J Laryngol Otol 1986;100:1375-83.
48. Meech RP, Campbell KC, Hughes LP, et al. A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis. Hear Res 1998;124:44-59.
49. Marcocci L, Packer L, Droy-Lefaix MT, et al. Antioxidant action of Ginkgo biloba extract EGb 761. Methods Enzymol 1994;234: 462-74.
50. Calapai G, Crupi A, Firenzuoli F, et al. Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci 2000;67:2673-83.
51. Kim KS, Rhee KH, Yoon JH, et al. Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells. Oral Oncol 2005;41:383-9.
52. Fukaya H, Kanno H. Experimental studies of protective studies of Ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats. Nippon Jibiinkoka Gakkai Kaiho 1999;102:907-17.
53. Xu O, Lu H, Li PQ, et al. Effect of combination of Ginkgo leaf extract and deferoxamine in preventing and treating ototoxicity of cisplatin. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004;24:915-8.
54. DeFeudis FV. Ginkgo biloba Extract (EGb 761): Pharmacological Activities and Clinical Application. Paris, France: Elsevier, 1991:143-6.
55. Sparreboom A, Cox MC, Acharya MR, et al. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004;22:2489-503.
56. Meijerman I, Beijnen JH, Schellens JH. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 2006;11:742-52.
57. McEvoy GK, ed. American Hospital Formulary Service: Drug Information. Bethesda, MD: American Society of Hospital Pharmacists, 1992.
58. Pretner E, Amri H, Li W, et al. Cancer-related overexpression of the peripheral-type benzodiazepine receptor and cytostatic anticancer effects of Ginkgo biloba extract (EGb 761). Anticancer Res 2006;26:9-22.
59. Chao JC, Chu CC. Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells. World J Gastroenterol 2004;10:37-41.
60. Hauns B, Haring B, Kohler S, et al. Phase II study with 5-fluorouracil and Ginkgo biloba extract (GBE 761 ONC) in patients with pancreatic cancer. Arzneimittelforschung 1999;49:1030-4.
61. Hauns B, Haring B, Kohler S, et al. Phase II study of combined 5-fluorouracil/Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer. Phytother Res 2001;15:34-8.